Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
125824787	12582478	7	F	20160713	20160817	20160722	20160818	EXP		IN-ROCHE-1796757	ROCHE		0.00				Y	0.00000		20160818		MD	IN	IN

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
125824787	12582478	1	PS	AVASTIN	BEVACIZUMAB	1	Other				U		B7034B02		125085

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
125824787	12582478	1	Product used for unknown indication

Outcome of event

Event ID	CASEID	OUTC COD
125824787	12582478	OT

Reactions reported

Event ID	CASEID	PT
125824787	12582478	Eye disorder
125824787	12582478	Eye infection
125824787	12582478	Eye inflammation
125824787	12582478	Eye irritation
125824787	12582478	Eye pain
125824787	12582478	Eye pruritus
125824787	12582478	Eye swelling
125824787	12582478	Lacrimation increased
125824787	12582478	Ocular hyperaemia
125824787	12582478	Off label use
125824787	12582478	Suspected transmission of an infectious agent via product
125824787	12582478	Vision blurred
125824787	12582478	Visual acuity reduced

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
125824787	12582478	1	20160712		0